TAVNEOS
Active substance: avacopan
CAPSULE · AVACOPAN 10 mg/1
United StatesActive
Marketing holder: ChemoCentryx, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- AVACOPAN · 10 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 2 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12099-e4a9-734d-ab15-028157083017;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73556-168
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 73556-168 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73556-168 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73556-168 · Verified 2026-10-09 · open in source